Caplyta 21 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F7CX6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,087
Award facts
- Contract value 100% obligated
- $10,086.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,086.74 to AmerisourceBergen Drug Corp for the supply of CAPLYTA 21 MG capsules (30-count units) under a firm fixed-price contract. The delivery order, issued on February 2, 2026, with an ultimate completion date of February 3, 2026, represents a non-set-aside, competitively awarded transaction. Performance of this order will be executed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., operates as a major pharmaceutical distributor providing critical medical supplies to federal healthcare systems supporting military and veteran populations.
This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the delivery of specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. The contract demonstrates the company's established capability to efficiently fulfill federal procurement requirements for essential pharmaceutical commodities required by military treatment facilities and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26F7CX6?
SPE2DR26F7CX6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 2, 2026.
How much is contract SPE2DR26F7CX6 worth?
The government has obligated $10,087 on SPE2DR26F7CX6.
Is contract SPE2DR26F7CX6 an order under another contract?
Yes. SPE2DR26F7CX6 is a delivery order under SPE2DR25D3504, an indefinite delivery contract.
Was contract SPE2DR26F7CX6 competed?
The extent of competition for SPE2DR26F7CX6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award